MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
The Oncologist
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

406 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
406 works in the cohort · of 4,299,418page 1 of 9

Labels cover 2 of 406 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 406 of 406 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Ewing's Sarcoma Family of Tumors: Current Management
Mark L. Bernstein, Heinrich Kovar, Michael Paulussen, R. Lor Randall, Andreas Schuck, Lisa A. Teot +1 more
2006· review· en· The Oncologist· Medicine
distilled prediction:candidate · noneconsensus · none
518
citations
affaboutunlabeled
Cancer in 15- to 29-Year-Olds by Primary Site
Archie Bleyer, Aaron D. Viny, Ronald D. Barr
2006· review· en· The Oncologist· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
268
citations
affgemma · no categorygpt · no categorymodels agree
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)
Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell, Angela DeMichele, Sherene Loi, Jungsil Ro +8 more
2016· article· en· The Oncologist· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
246
citations
affunlabeled
The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response
Donald S. Kaufman, Kathryn Winter, William U. Shipley, Niall M. Heney, Michael Chetner, Luís Souhami +3 more
2000· article· en· The Oncologist· Medicine
distilled prediction:candidate · noneconsensus · none
218
citations
affunlabeled
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Pascale Tomasini, Preet Walia, Catherine Labbé, Kevin Jao, Natasha B. Leighl
2016· review· en· The Oncologist· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
135
citations
affno abstractunlabeled
The Cell Cycle
E.D. Israels, L. G. Israels
2000· article· en· The Oncologist
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
84
citations
next →

How this was built: Screen · Findings · About